AMIGO2 and gastric cancer: We found that AMIGO2, a liver metastasis driver molecule, was transferred from human gastric cancer cells to hepatic sinusoidal endothelial cells via tumor-derived EVs, and that the AMIGO2 delivered by EVs enhanced the adhesion of endothelial cells to cancer cells.